COST-EFFECTIVENESS OF TRIPLE THERAPY WITH TELAPREVIR FOR THE TREATMENT OF TREATMENT-NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS IN GERMANY

被引：0
|
作者：
Stahmeyer, J. T. [1 ]
Schauer, S. [1 ]
Wirth, D. [2 ]
Fleischmann, J. [3 ]
Lee, S. [4 ]
Gavart, S. [5 ]
Bianic, F. [6 ]
Cure, S. [7 ]
Krauth, C. [1 ]
机构：
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] Janssen Cilag GmbH, Neuss, Germany
[3] Janssen Cilag Germany, Neuss, Germany
[4] Co Johnson & Johnson, Janssen Global Serv, Horsham, PA USA
[5] Janssen Pharmaceut, B-2340 Beerse, Belgium
[6] OptumInsight, Nanterre, France
[7] OptumInsight, Uxbridge, Middx, England
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1129
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A396 / A396
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus
    Fawsitt, Christopher G.
    Vickerman, Peter
    Cooke, Graham S.
    Welton, Nicky J.
    Barnes, Eleanor
    Ball, Jonathan
    Brainard, Diana
    Burgess, Gary
    Dillon, John
    Foster, Graham
    Gore, Charles
    Guha, Neil
    Halford, Rachel
    Whitby, Kevin
    Holmes, Chris
    Howe, Anita
    Hudson, Emma
    Hutchinson, Sharon
    Irving, William
    Khakoo, Salim
    Klenerman, Paul
    Martin, Natasha
    Massetto, Benedetta
    Mbisa, Tamyo
    McHutchison, John
    McKeating, Jane
    McLauchlan, John
    Miners, Alec
    Murray, Andrea
    Shaw, Peter
    Simmonds, Peter
    Spencer, Chris
    Thomson, Emma
    Zitzmann, Nicole
    [J]. VALUE IN HEALTH, 2020, 23 (02) : 180 - 190
  • [32] COST PER CURE OF TELAPREVIR AND BOCEPREVIR IN TREATMENT-NAIVE GENOTYPE 1 HEPATITIS C PATIENTS WITH F2 FIBROSIS IN BRAZIL
    Morais, A. D.
    Pereira, M. L.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A352 - A352
  • [33] COST EFFECTIVENESS OF TRIPLE THERAPY FOR ADULTS PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C
    Araujo, R. L.
    Vianna, C. M.
    Mosegui, G. B.
    Rodrigues, M. P.
    Valle, P. M.
    Felicissimo, T.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A872 - A872
  • [34] Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C
    Buti, M
    Casado, MA
    Fosbrook, L
    Wong, JB
    Esteban, R
    [J]. JOURNAL OF HEPATOLOGY, 2000, 33 (04) : 651 - 658
  • [35] Exposure-Response Relationships in Telaprevir Combination Therapy in Treatment-NaiVE Genotype 1 Chronic HCV Patients
    Gordon, Stuart C.
    Muir, Andrew J.
    Garg, Varun
    Henshaw, Joshua W.
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S931 - S931
  • [36] EXPOSURE-RESPONSE RELATIONSHIPS IN TELAPREVIR COMBINATION THERAPY IN TREATMENT-NAIVE GENOTYPE 1 CHRONIC HCV PATIENTS
    Gordon, S. C.
    Muir, A. J.
    Garg, V.
    Henshaw, J.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S440 - S440
  • [37] Cost-Effectiveness of Sofosbuvir-Based Triple Therapy for Untreated Patients With Genotype 1 Chronic Hepatitis C
    Petta, Salvatore
    Cabibbo, Giuseppe
    Enea, Marco
    Macaluso, Fabio Salvatore
    Plaia, Antonella
    Bruno, Raffaele
    Gasbarrini, Antonio
    Craxi, Antonio
    Camma, Calogero
    [J]. HEPATOLOGY, 2014, 59 (05) : 1692 - 1705
  • [38] Health-related quality of life in genotype 1 treatment-naive chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study
    Vera-Llonch, M.
    Martin, M.
    Aggarwal, J.
    Donepudi, M.
    Bayliss, M.
    Goss, T.
    Younossi, Z.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (02) : 124 - 133
  • [39] THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS
    Curtis, S.
    Cure, S.
    Gavart, S.
    Dearden, L.
    Fleischmann, J.
    Ouwens, M.
    Lee, S.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S434 - S434
  • [40] Hepatitis C Viral Evolution in Genotype 1 Treatment-Naive and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials
    Kieffer, Tara L.
    De Meyer, Sandra
    Bartels, Doug J.
    Sullivan, James C.
    Zhang, Eileen Z.
    Tigges, Ann
    Dierynck, Inge
    Spanks, Joan
    Dorrian, Jennifer
    Jiang, Min
    Adiwijaya, Bambang
    Ghys, Anne
    Beumont, Maria
    Kauffman, Robert S.
    Adda, Nathalie
    Jacobson, Ira M.
    Sherman, Kenneth E.
    Zeuzem, Stefan
    Kwong, Ann D.
    Picchio, Gaston
    [J]. PLOS ONE, 2012, 7 (04):
12345